Drug intelligence / Profile preview

Alacare (aminolevulinic acid)

Development stage
Unknown
Lead developer
photonamic
Modality
Small Molecules
Administration
Topical
01

Overview

Alacare is a medicated patch (plaster) containing 5-aminolevulinic acid (5-ALA), developed by photonamic GmbH & Co. KG for the treatment of actinic keratosis. It is designed for use in photodynamic therapy (PDT). When applied to the skin, the 5-ALA in the patch is absorbed by the lesion and metabolized via the heme biosynthetic pathway into protoporphyrin IX (PpIX), a potent photosensitizer. Upon subsequent exposure to red light, PpIX absorbs the energy and reacts with oxygen to produce singlet oxygen and other reactive oxygen species (ROS). These ROS cause oxidative damage to cellular components, leading to the selective destruction of the dysplastic keratinocytes. The patch formulation provides a standardized dose of 4 mg 5-ALA per patch (8 mg/cm²), simplifying the application process compared to traditional gels or creams. It is primarily indicated for mild actinic keratosis on the face and scalp, with ongoing research into its efficacy for lesions on the upper extremities.

Brand names
Alacare
Other names
5-aminolevulinic acid5-ALAaminolevulinic acid hydrochloride
02

Targets

TSPO (Translocator Protein (18 kDa))FECH (Ferrochelatase)

Beyond the preview

Go deeper on Alacare (aminolevulinic acid).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alacare (aminolevulinic acid).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call